Document is current

Any future updates will be listed below

Risedronate therapy in patients with mild-to-moderate chronic kidney disease with osteoporosis: post-hoc analysis of data from the risedronate phase III clinical trials

Crossref DOI link: https://doi.org/10.1186/s12882-017-0478-9

Published Online: 2017-02-15

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark